Company Overview
Triple Threat Communications (TTC) is a full-service healthcare and digital marketing firm encompassing the entire healthcare marketing spectrum, from pre- to post-launch with an employment model that allows it to deploy senior talent quickly and efficiently.
TTC’s specialized team delivers strategic and impactful solutions in pharmaceutical marketing, including brand strategy, creative campaign development, digital marketing, content creation, and targeted promotional initiatives.
Deerfield Agency is a full-service, data-driven healthcare marketing partner that steers pharma, biotech, and health-tech brands from strategic positioning to omnichannel launch and lifecycle communications.
Historically, TTC has either outsourced specific projects or lacked the capacity to undertake others, presenting significant untapped revenue opportunities for immediate pursuit from the outset of Deerfield’s acquisition
Transaction Highlights
The shareholders of Triple Threat Communications (TTC) were seeking an exit to a strategic partner to achieve liquidity and transition ownership of the company.
PanArgent Capital Advisors acted as Sole Financial Advisor to the shareholders of TTC on the sale of the company. PanArgent Capital Advisors ran a highly competitive process, introducing a range of strategic buyers and private equity firms, with careful management of the deal process and due diligence ensuring a thorough assessment of each opportunity.
After Deerfield was chosen as the best suiter, concerns about TTC’s customer concentration stalled due diligence, we successfully addressed these concerns by emphasizing the stability of TTC’s key client relationship and the growth potential through cross-selling.
This approach secured a favorable valuation for the shareholders.With this acquisition, Deerfield gains accesses to major clients within the pharmaceutical sector, further strengthening its suite of services and gaining strong cross-selling opportunities.
